Kyverna Therapeutics (KYTX) Update / Briefing Transcript

Kyverna Therapeutics (KYTX) Update / Briefing August 28, 2025 11:00 AM ET Company ParticipantsJessica Serra - Head - IRWarner Biddle - CEO & DirectorRicardo Grieshaber-Bouyer - Professor - Clinical Systems ImmunologySham Dholakia - Chief Product OfficerNaji Gehchan - Chief Medical & Development OfficerAiden Haghikia - Director - Department of Neurology & Clinical NeurophysiologySrikanth Muppidi - Clinical Professor & Adult NeurologyDan Maziasz - Chief Business OfficerJessica SerraGood morning, and thank you ...